Cav1.1

1

Liu Y et al. Unique Expression of Angiotensin Type-2 Receptor in Sex-Specific Distribution of Myelinated Ah-Type Baroreceptor Neuron Contributing to Sex-Dimorphic Neurocontrol of Circulation.
Hypertension, 2016 Feb 16 , ().

2

Kim H et al. Protein Network Interacting with BK Channels.
Int. Rev. Neurobiol., 2016 , 128 (127-61).

3

Georgiou DK et al. Ca2+ Binding/Permeation via Calcium Channel, CaV1.1, Regulates the Intracellular Distribution of the Fatty Acid Transport Protein, CD36, and Fatty Acid Metabolism.
J. Biol. Chem., 2015 Sep 25 , 290 (23751-65).

4

Zhang YY et al. KCa1.1 is potential marker for distinguishing Ah-type baroreceptor neurons in NTS and contributes to sex-specific presynaptic neurotransmission in baroreflex afferent pathway.
Neurosci. Lett., 2015 Sep 14 , 604 (1-6).

5

Yu L et al. Unoprostone activation of BK (KCa1.1) channel splice variants.
Biochim. Biophys. Acta, 2015 Nov , 1848 (2859-67).

6

Golder FJ et al. Identification and Characterization of GAL-021 as a Novel Breathing Control Modulator.
Anesthesiology, 2015 Nov , 123 (1093-104).

7

Fiszer D et al. Next-generation Sequencing of RYR1 and CACNA1S in Malignant Hyperthermia and Exertional Heat Illness.
Anesthesiology, 2015 May , 122 (1033-46).

8

Benedetti B et al. Physiological and pharmacological modulation of the embryonic skeletal muscle calcium channel splice variant CaV1.1e.
Biophys. J., 2015 Mar 10 , 108 (1072-80).

9

Jia BX et al. Muscle edema of the lower limb determined by MRI in Asian hypokalaemic periodic paralysis patients.
Neurol. Res., 2015 Mar , 37 (246-52).

10

Ma Y et al. Epoxyeicosatrienoic acids act through TRPV4-TRPC1-KCa1.1 complex to induce smooth muscle membrane hyperpolarization and relaxation in human internal mammary arteries.
Biochim. Biophys. Acta, 2015 Mar , 1852 (552-9).

11

Gillies RL et al. Analysis of the entire ryanodine receptor type 1 and alpha 1 subunit of the dihydropyridine receptor (CACNA1S) coding regions for variants associated with malignant hyperthermia in Australian families.
Anaesth Intensive Care, 2015 Mar , 43 (157-66).

12

Dominguez Rieg JA et al. P2Y₂ receptor activation decreases blood pressure via intermediate conductance potassium channels and connexin 37.
Acta Physiol (Oxf), 2015 Mar , 213 (628-41).

13

Grajales L et al. Temporal expression of calcium channel subunits in satellite cells and bone marrow mesenchymal cells.
Stem Cell Rev, 2015 Jun , 11 (408-22).

14

Xu WX et al. KCa1.1 β4-subunits are not responsible for iberiotoxin-resistance in baroreceptor neurons in adult male rats.
Int. J. Cardiol., 2015 Jan 15 , 178 (184-7).

15

Polster A et al. Stac adaptor proteins regulate trafficking and function of muscle and neuronal L-type Ca2+ channels.
Proc. Natl. Acad. Sci. U.S.A., 2015 Jan 13 , 112 (602-6).

16

Tanner MR et al. KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritis.
, 2015 Jan , 67 (96-106).

17

Lopez RJ et al. Raptor ablation in skeletal muscle decreases Cav1.1 expression and affects the function of the excitation-contraction coupling supramolecular complex.
Biochem. J., 2015 Feb 15 , 466 (123-35).

18

Oliván-Viguera A et al. A novel pan-negative-gating modulator of KCa2/3 channels, fluoro-di-benzoate, RA-2, inhibits endothelium-derived hyperpolarization-type relaxation in coronary artery and produces bradycardia in vivo.
Mol. Pharmacol., 2015 Feb , 87 (338-48).

19

Turner RW et al. Neuronal expression of the intermediate conductance calcium-activated potassium channel KCa3.1 in the mammalian central nervous system.
Pflugers Arch., 2015 Feb , 467 (311-28).

20

Wu J et al. Structure of the voltage-gated calcium channel Cav1.1 complex.
Science, 2015 Dec 18 , 350 (aad2395).

21

Liu Y et al. KCa1.1-mediated frequency-dependent central and peripheral neuromodulation via Ah-type baroreceptor neurons located within nodose ganglia and nucleus of solitary tract of female rats.
Int. J. Cardiol., 2015 Apr 15 , 185 (84-7).

22

Ohrtman JD et al. Apparent lack of physical or functional interaction between CaV1.1 and its distal C terminus.
J. Gen. Physiol., 2015 Apr , 145 (303-14).

23

Cannon SC Channelopathies of skeletal muscle excitability.
Compr Physiol, 2015 Apr , 5 (761-90).

24

Parajuli SP et al. Functional link between muscarinic receptors and large-conductance Ca2+ -activated K+ channels in freshly isolated human detrusor smooth muscle cells.
Pflugers Arch., 2015 Apr , 467 (665-75).

25

Berthier C et al. Depression of voltage-activated Ca2+ release in skeletal muscle by activation of a voltage-sensing phosphatase.
J. Gen. Physiol., 2015 Apr , 145 (315-30).

26

Hernãndez-Ochoa EO et al. Critical Role of Intracellular RyR1 Calcium Release Channels in Skeletal Muscle Function and Disease.
Front Physiol, 2015 , 6 (420).

27

Antony C et al. Regulation of L-type Voltage Gated Calcium Channel CACNA1S in Macrophages upon Mycobacterium tuberculosis Infection.
PLoS ONE, 2015 , 10 (e0124263).

28

Liu XL et al. Mutations of SCN4A gene cause different diseases: 2 case reports and literature review.
Channels (Austin), 2015 , 9 (82-7).

29

Subramanian M et al. Idiopathic generalized epilepsy and hypokalemic periodic paralysis in a family of South Indian descent.
Case Rep Neurol Med, 2015 , 2015 (906049).

30

Rabjerg M et al. High expression of KCa3.1 in patients with clear cell renal carcinoma predicts high metastatic risk and poor survival.
PLoS ONE, 2015 , 10 (e0122992).

31

Mahalingam M et al. Structural mapping of divergent regions in the type 1 ryanodine receptor using fluorescence resonance energy transfer.
Structure, 2014 Sep 2 , 22 (1322-32).

32

Petkov GV Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2014 Sep 15 , 307 (R571-84).

33

Bartok A et al. Margatoxin is a non-selective inhibitor of human Kv1.3 K(+) channels.
Toxicon, 2014 Sep , 87 (6-16).

34

Stunnenberg BC et al. Cardiac arrhythmias in hypokalemic periodic paralysis: Hypokalemia as only cause?
Muscle Nerve, 2014 Sep , 50 (327-32).

35

Nausch B et al. NS19504: a novel BK channel activator with relaxing effect on bladder smooth muscle spontaneous phasic contractions.
J. Pharmacol. Exp. Ther., 2014 Sep , 350 (520-30).

36

Zhang P et al. Nitric oxide and protein kinase G act on TRPC1 to inhibit 11,12-EET-induced vascular relaxation.
Cardiovasc. Res., 2014 Oct 1 , 104 (138-46).

37

Ge L et al. Big Potassium (BK) ion channels in biology, disease and possible targets for cancer immunotherapy.
Int. Immunopharmacol., 2014 Oct , 22 (427-43).

38

Beqollari D et al. Differential effects of RGK proteins on L-type channel function in adult mouse skeletal muscle.
Biophys. J., 2014 May 6 , 106 (1950-7).

39

Toro L et al. MaxiK channel and cell signalling.
Pflugers Arch., 2014 May , 466 (875-86).

40

Climent B et al. Effects of obesity on vascular potassium channels.
Curr Vasc Pharmacol, 2014 May , 12 (438-52).

41

Na SJ et al. Whole-genome analysis in Korean patients with autoimmune myasthenia gravis.
Yonsei Med. J., 2014 May , 55 (660-8).

42

Chaube R et al. Regulation of the skeletal muscle ryanodine receptor/Ca2+-release channel RyR1 by S-palmitoylation.
J. Biol. Chem., 2014 Mar 21 , 289 (8612-9).

43

Tummala SR et al. Localization of Cacna1s to ON bipolar dendritic tips requires mGluR6-related cascade elements.
Invest. Ophthalmol. Vis. Sci., 2014 Mar , 55 (1483-92).

44

Fuller MD et al. Differential regulation of CaV1.2 channels by cAMP-dependent protein kinase bound to A-kinase anchoring proteins 15 and 79/150.
J. Gen. Physiol., 2014 Mar , 143 (315-24).

45

Taylor J et al. The Cavβ1a subunit regulates gene expression and suppresses myogenin in muscle progenitor cells.
J. Cell Biol., 2014 Jun 23 , 205 (829-46).

46

Wu CT et al. Disease and region-related cardiac fibroblast potassium current variations and potential functional significance.
Cardiovasc. Res., 2014 Jun 1 , 102 (487-96).

47

Li HJ et al. Chlorpromazine confers neuroprotection against brain ischemia by activating BKCa channel.
Eur. J. Pharmacol., 2014 Jul 15 , 735 (38-43).

48

Ruchala I et al. Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels.
Cell Calcium, 2014 Jul , 56 (25-33).

49

Turner RW et al. T-type channels buddy up.
Pflugers Arch., 2014 Jan 11 , ().

50

Hernãndez-Ochoa EO et al. β1a490-508, a 19-residue peptide from C-terminal tail of Cav1.1 β1a subunit, potentiates voltage-dependent calcium release in adult skeletal muscle fibers.
Biophys. J., 2014 Feb 4 , 106 (535-47).

51

Sheng J et al. Electrophysiology of human cardiac atrial and ventricular telocytes.
J. Cell. Mol. Med., 2014 Feb , 18 (355-62).

52

Wang Y et al. [Ca(2+)-activated K(+) channel switching in smooth muscle participates in atherosclerosis development in diabetic rats].
Nan Fang Yi Ke Da Xue Xue Bao, 2014 Feb , 34 (188-92).

53

Stowell KM DNA testing for malignant hyperthermia: the reality and the dream.
Anesth. Analg., 2014 Feb , 118 (397-406).

54

Larach MG et al. Malignant hyperthermia deaths related to inadequate temperature monitoring, 2007-2012: a report from the North American malignant hyperthermia registry of the malignant hyperthermia association of the United States.
Anesth. Analg., 2014 Dec , 119 (1359-66).

55

Sánchez-Pastor E et al. Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit.
Eur. J. Pharmacol., 2014 Apr 15 , 729 (100-6).

56

Kunert-Keil CH et al. Differential expression of genes involved in the calcium homeostasis in masticatory muscles of MDX mice.
J. Physiol. Pharmacol., 2014 Apr , 65 (317-24).

57

Robert V et al. Protein kinase C-dependent activation of CaV1.2 channels selectively controls human TH2-lymphocyte functions.
J. Allergy Clin. Immunol., 2014 Apr , 133 (1175-83).

58

Takacs Z et al. Interaction of the BKCa channel gating ring with dendrotoxins.
Channels (Austin), 2014 , 8 (421-32).

59

Watanabe A et al. In silico identification of the genes for sperm-egg interaction in the internal fertilization of the newt Cynops pyrrhogaster.
Int. J. Dev. Biol., 2014 , 58 (873-9).

60

Lau K et al. Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain.
Nat Commun, 2014 , 5 (5397).

61

Zapata M et al. Molecular cloning of ion channels in Felis catus that are related to periodic paralyses in man: a contribution to the understanding of the genetic susceptibility to feline neck ventroflexion and paralysis.
Biol Open, 2014 , 3 (785-93).

62

Yang B et al. A rare case of unilateral adrenal hyperplasia accompanied by hypokalaemic periodic paralysis caused by a novel dominant mutation in CACNA1S: features and prognosis after adrenalectomy.
BMC Urol, 2014 , 14 (96).

63

Guerrero-Hernández A et al. Ryanodine receptors as leak channels.
Eur. J. Pharmacol., 2013 Nov 28 , ().

64

Kim JH et al. Exome sequencing reveals novel rare variants in the ryanodine receptor and calcium channel genes in malignant hyperthermia families.
Anesthesiology, 2013 Nov , 119 (1054-65).

65

Gonsalves SG et al. Using exome data to identify malignant hyperthermia susceptibility mutations.
Anesthesiology, 2013 Nov , 119 (1043-53).

66

Yu ZH et al. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
Pharmacol. Res., 2013 Nov , 77 (30-8).

67

Bannister RA et al. Impaired gating of an L-Type Ca(2+) channel carrying a mutation linked to malignant hyperthermia.
Biophys. J., 2013 May 7 , 104 (1917-22).

68

Campiglio M et al. Stable incorporation versus dynamic exchange of β subunits in a native Ca2+ channel complex.
J. Cell. Sci., 2013 May 1 , 126 (2092-101).

69

Stoneking CJ et al. Voltage dependence of the Ca(2+)-activated K(+) channel K(Ca)3.1 in human erythroleukemia cells.
Am. J. Physiol., Cell Physiol., 2013 May 1 , 304 (C858-72).

70

Brandom BW et al. Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States.
Anesth. Analg., 2013 May , 116 (1078-86).

71

Hanchard NA et al. Exploring the utility of whole-exome sequencing as a diagnostic tool in a child with atypical episodic muscle weakness.
Clin. Genet., 2013 May , 83 (457-61).

72

Jorquera G et al. Cav1.1 controls frequency-dependent events regulating adult skeletal muscle plasticity.
J. Cell. Sci., 2013 Mar 1 , 126 (1189-98).

73

Eltit JM et al. Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia.
FASEB J., 2013 Mar , 27 (991-1000).

74

Takai J et al. Laminar shear stress upregulates endothelial Ca2+-activated K+ channels KCa2.3 and KCa3.1 via a Ca2+/calmodulin-dependent protein kinase kinase/Akt/p300 cascade.
Am. J. Physiol. Heart Circ. Physiol., 2013 Jun 21 , ().

75

Park WS et al. Functional expression of smooth muscle-specific ion channels in TGF-β1-treated human adipose-derived mesenchymal stem cells.
Am. J. Physiol., Cell Physiol., 2013 Jun 12 , ().

76

Engbers JD et al. Modeling interactions between voltage-gated Ca ( 2+) channels and KCa1.1 channels.
Channels (Austin), 2013 Jul 31 , 7 ().

77

Zhang YY et al. BKCa and hEag1 channels regulate cell proliferation and differentiation in human bone marrow-derived mesenchymal stem cells.
J. Cell. Physiol., 2013 Jul 23 , ().

78

Nam TS et al. An algorithm for candidate sequencing in non-dystrophic skeletal muscle channelopathies.
J. Neurol., 2013 Jul , 260 (1770-7).

79

Suzuki Y et al. Direct molecular interaction of caveolin-3 with KCa1.1 channel in living HEK293 cell expression system.
Biochem. Biophys. Res. Commun., 2013 Jan 18 , 430 (1169-74).

80

Ke Q et al. Gender differences in penetrance and phenotype in hypokalemic periodic paralysis.
Muscle Nerve, 2013 Jan , 47 (41-5).

81

Schiemann AH et al. Sequence capture and massively parallel sequencing to detect mutations associated with malignant hyperthermia.
Br J Anaesth, 2013 Jan , 110 (122-7).

82

Wei CJ et al. [Clinical and molecular genetic analysis of a family with normokalemic periodic paralysis].
Zhonghua Er Ke Za Zhi, 2013 Jan , 51 (47-51).

83

Fritsch EB et al. Triclosan impairs swimming behavior and alters expression of excitation-contraction coupling proteins in fathead minnow (Pimephales promelas).
Environ. Sci. Technol., 2013 Feb 19 , 47 (2008-17).

84

Yang Y et al. Function of BKCa channels is reduced in human vascular smooth muscle cells from Han Chinese patients with hypertension.
Hypertension, 2013 Feb , 61 (519-25).

85

Wu F et al. Beneficial effects of bumetanide in a CaV1.1-R528H mouse model of hypokalaemic periodic paralysis.
Brain, 2013 Dec , 136 (3766-74).

86

Novaković R et al. The effect of resveratrol on contractility of non-pregnant rat uterus: the contribution of K(+) channels.
J. Physiol. Pharmacol., 2013 Dec , 64 (795-805).

87

Lee EJ et al. Transthyretin is a key regulator of myoblast differentiation.
PLoS ONE, 2013 , 8 (e63627).

88

Valladares D et al. Electrical stimuli are anti-apoptotic in skeletal muscle via extracellular ATP. Alteration of this signal in Mdx mice is a likely cause of dystrophy.
PLoS ONE, 2013 , 8 (e75340).

89

Rehak R et al. Low voltage activation of KCa1.1 current by Cav3-KCa1.1 complexes.
PLoS ONE, 2013 , 8 (e61844).

90

Taiakina V et al. The calmodulin-binding, short linear motif, NSCaTE is conserved in L-type channel ancestors of vertebrate Cav1.2 and Cav1.3 channels.
PLoS ONE, 2013 , 8 (e61765).

91

Lefebvre R et al. Ca2+ release in muscle fibers expressing R4892W and G4896V type 1 ryanodine receptor disease mutants.
PLoS ONE, 2013 , 8 (e54042).

92

Wu W et al. Cholesterol down-regulates BK channels stably expressed in HEK 293 cells.
PLoS ONE, 2013 , 8 (e79952).

93

Oliván-Viguera A et al. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
PLoS ONE, 2013 , 8 (e58614).

94

Xin W et al. Constitutively active phosphodiesterase activity regulates urinary bladder smooth muscle function: critical role of KCa1.1 channel.
Am. J. Physiol. Renal Physiol., 2012 Nov 1 , 303 (F1300-6).

95

Hu X et al. KCa1.1 potassium channels regulate key proinflammatory and invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis.
J. Biol. Chem., 2012 Feb 3 , 287 (4014-22).

96

Zhang J et al. Regulation of Cell Proliferation of Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells via Ether a go-go 1 (hEAG1) Potassium Channel.
, 2012 Feb 22 , ().

97

Parker MD et al. HCO3--independent conductance with a mutant Na/HCO3 cotransporter (SLC4A4) in a case of proximal renal tubular acidosis with hypokalemic paralysis.
, 2012 Feb 13 , ().

98

Li FF et al. A novel mutation in CACNA1S gene associated with hypokalemic periodic paralysis which has a gender difference in the penetrance.
J. Mol. Neurosci., 2012 Feb , 46 (378-83).

99

George AL Leaky channels make weak muscles.
J. Clin. Invest., 2012 Dec 3 , 122 (4333-6).

100

Wu F et al. A calcium channel mutant mouse model of hypokalemic periodic paralysis.
J. Clin. Invest., 2012 Dec 3 , 122 (4580-91).

101

Schild JH et al. Differential distribution of voltage-gated channels in myelinated and unmyelinated baroreceptor afferents.
Auton Neurosci, 2012 Dec 24 , 172 (4-12).

102

Zhang J et al. Role of the BK channel (KCa1.1) during activation of electrogenic K+ secretion in guinea pig distal colon.
Am. J. Physiol. Gastrointest. Liver Physiol., 2012 Dec 15 , 303 (G1322-34).

103

Song YW et al. Normokalemic periodic paralysis is not a distinct disease.
Muscle Nerve, 2012 Dec , 46 (914-6).

104

Horrigan FT Perspectives on: Conformational coupling in ion channels: Conformational coupling in BK potassium channels.
J. Gen. Physiol., 2012 Dec , 140 (625-34).

105

Yamamura H et al. Molecular assembly and dynamics of fluorescent protein-tagged single KCa1.1 channel in expression system and vascular smooth muscle cells.
Am. J. Physiol., Cell Physiol., 2012 Apr 15 , 302 (C1257-68).

106

Sung CC et al. Genotype and phenotype analysis of patients with sporadic periodic paralysis.
Am. J. Med. Sci., 2012 Apr , 343 (281-5).

107

Evans AM et al. Ion Channel Regulation by the LKB1-AMPK Signalling Pathway: The Key to Carotid Body Activation by Hypoxia and Metabolic Homeostasis at the Whole Body Level.
Adv. Exp. Med. Biol., 2012 , 758 (81-90).

108

Krasnyĭ AM et al. [The expression of genes encoding the voltage-dependent L-type Ca2+ channels in proliferating and differentiating C2C12 myoblasts of mice].
Izv. Akad. Nauk. Ser. Biol., 2011 May-Jun , (349-53).

109

Wu F et al. A sodium channel knockin mutant (NaV1.4-R669H) mouse model of hypokalemic periodic paralysis.
J. Clin. Invest., 2011 Oct 3 , 121 (4082-94).

110

Hirano M et al. A novel mutation in the calcium channel gene in a family with hypokalemic periodic paralysis.
J. Neurol. Sci., 2011 Oct 15 , 309 (9-11).

111

Banas K et al. The KATP channel Kir6.2 subunit content is higher in glycolytic than oxidative skeletal muscle fibers.
Am. J. Physiol. Regul. Integr. Comp. Physiol., 2011 Oct , 301 (R916-25).

112

Burge JA et al. Novel Insights into the Pathomechanisms of Skeletal Muscle Channelopathies.
, 2011 Nov 15 , ().

113

Kim H et al. Hypokalemic periodic paralysis; two different genes responsible for similar clinical manifestations.
Korean J Pediatr, 2011 Nov , 54 (473-6).

114

Francis DG et al. Leaky sodium channels from voltage sensor mutations in periodic paralysis, but not paramyotonia.
Neurology, 2011 May 10 , 76 (1635-41).

115

Tammaro A et al. Novel missense mutations and unexpected multiple changes of RYR1 gene in 75 malignant hyperthermia families.
Clin. Genet., 2011 May , 79 (438-47).

116

Xiao Z et al. [The relationships between the single nueleotide polymorphisms of CACNA1S gene 11 exon and thyrotoxic hypokalemic periodic paralysis in the people of Han Nationality in Sichuan Province, China].
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2011 Jun , 28 (547-52, 558).

117

Li BY et al. KCa1.1 channel contributes to cell excitability in unmyelinated but not myelinated rat vagal afferents.
Am. J. Physiol., Cell Physiol., 2011 Jun , 300 (C1393-403).

118

Kraeva N et al. Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population.
Can J Anaesth, 2011 Jun , 58 (504-13).

119

Delbono O Expression and regulation of excitation-contraction coupling proteins in aging skeletal muscle.
Curr Aging Sci, 2011 Dec , 4 (248-59).

120

He ML et al. Effects of ion channels on proliferation in cultured human cardiac fibroblasts.
J. Mol. Cell. Cardiol., 2011 Aug , 51 (198-206).

121

Stroffekova K The IQ motif is crucial for Cav1.1 function.
J. Biomed. Biotechnol., 2011 , 2011 (504649).

122

Kryshtal' DA et al. [Changes in calcium-dependent potassium channels of isolated smooth muscle cells of the bladder in rats with experimental diabetes].
Fiziol Zh, 2011 , 57 (25-32).

123

Incecik F et al. Hypokalemic periodic paralysis due to the SCN4A R672H mutation in a Turkish family.
Turk. J. Pediatr., 2010 Jul-Aug , 52 (409-10).

124

Raja Rayan DL et al. Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis.
Curr. Opin. Neurol., 2010 Oct , 23 (466-76).

125

Kil TH et al. Severe respiratory phenotype caused by a de novo Arg528Gly mutation in the CACNA1S gene in a patient with hypokalemic periodic paralysis.
Eur. J. Paediatr. Neurol., 2010 May , 14 (278-81).

126

Sorensen MV et al. Adrenaline-induced colonic K+ secretion is mediated via KCa1.1 (BK) channel.
, 2010 Mar 29 , ().

127

Zhou H et al. Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene.
Neuromuscul. Disord., 2010 Mar , 20 (166-73).

128

Li J et al. Skeletal phenotype of mice with a null mutation in Cav 1.3 L-type calcium channel.
J Musculoskelet Neuronal Interact, 2010 Jun , 10 (180-7).

129

Toppin PJ et al. A report of fulminant malignant hyperthermia in a patient with a novel mutation of the CACNA1S gene.
Can J Anaesth, 2010 Jul , 57 (689-93).

130

Cannon SC Voltage-Sensor Mutations in Channelopathies of Skeletal Muscle.
, 2010 Feb 15 , ().

131

Sorensen MV et al. Colonic potassium handling.
, 2010 Feb 10 , ().

132

Matthews E et al. Muscle channelopathies: does the predicted channel gating pore offer new treatment options for hypokalaemic periodic paralysis?
, 2010 Feb 1 , ().

133

Pirone A et al. Identification and functional characterization of malignant hyperthermia mutation T1354S in the outer pore of the Cavalpha1S-subunit.
Am. J. Physiol., Cell Physiol., 2010 Dec , 299 (C1345-54).

134

Schicker KW et al. P2Y1 receptors mediate an activation of neuronal calcium-dependent K+ channels.
, 2010 Aug 2 , ().

135

Chiu YH et al. Dominant-negative regulation of cell surface expression by a pentapeptide motif at the extreme COOH terminus of an Slo1 calcium-activated potassium channel splice variant.
Mol. Pharmacol., 2010 Apr , 77 (497-507).

136

Xu X et al. Long-term fish oil supplementation induces cardiac electrical remodeling by changing channel protein expression in the rabbit model.
PLoS ONE, 2010 , 5 (e10140).

137

Taylor JR et al. Increased CaVbeta1A expression with aging contributes to skeletal muscle weakness.
Aging Cell, 2009 Sep , 8 (584-94).

138

Sones WR et al. Inhibition of vascular calcium-gated chloride currents by blockers of KCa1.1, but not by modulators of KCa2.1 or KCa2.3 channels.
Br. J. Pharmacol., 2009 Sep , 158 (521-31).

139

Bentzen BH et al. Synthesis and characterisation of NS13558: a new important tool for addressing KCa1.1 channel function ex vivo.
, 2009 Oct 2 , ().

140

Ke T et al. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a South American family.
J. Hum. Genet., 2009 Nov , 54 (660-4).

141

Matthews E et al. Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis.
Neurology, 2009 May 5 , 72 (1544-7).

142

Harron SA et al. Volume regulation in the human airway epithelial cell line Calu-3.
Can. J. Physiol. Pharmacol., 2009 May , 87 (337-46).

143

Jurkat-Rott K et al. K+-dependent paradoxical membrane depolarization and Na+ overload, major and reversible contributors to weakness by ion channel leaks.
Proc. Natl. Acad. Sci. U.S.A., 2009 Mar 10 , 106 (4036-41).

144

Kaufmann WA et al. Large-conductance calcium-activated potassium channels in purkinje cell plasma membranes are clustered at sites of hypolemmal microdomains.
J. Comp. Neurol., 2009 Jul 10 , 515 (215-30).

145

Tuluc P et al. A CaV1.1 Ca2+ channel splice variant with high conductance and voltage-sensitivity alters EC coupling in developing skeletal muscle.
Biophys. J., 2009 Jan , 96 (35-44).

146

Maffè S et al. Atypical arrhythmic complications in familial hypokalemic periodic paralysis.
J Cardiovasc Med (Hagerstown), 2009 Jan , 10 (68-71).

147

Poulsen AN et al. Differential expression of BK channel isoforms and beta-subunits in rat neuro-vascular tissues.
Biochim. Biophys. Acta, 2009 Feb , 1788 (380-9).

148

Hu H et al. Characterization of ion channels in human preadipocytes.
J. Cell. Physiol., 2009 Feb , 218 (427-35).

149

Specht D et al. Effects of presynaptic mutations on a postsynaptic Cacna1s calcium channel colocalized with mGluR6 at mouse photoreceptor ribbon synapses.
Invest. Ophthalmol. Vis. Sci., 2009 Feb , 50 (505-15).

150

Köhler R Single-nucleotide polymorphisms in vascular Ca(2+)-activated K (+)-channel genes and cardiovascular disease.
, 2009 Dec 31 , ().

151

Takacs Z et al. A designer ligand specific for Kv1.3 channels from a scorpion neurotoxin-based library.
Proc. Natl. Acad. Sci. U.S.A., 2009 Dec 29 , 106 (22211-6).

152

Levano S et al. Increasing the number of diagnostic mutations in malignant hyperthermia.
Hum. Mutat., 2009 Apr , 30 (590-8).

153

Carpenter D et al. The role of CACNA1S in predisposition to malignant hyperthermia.
BMC Med. Genet., 2009 , 10 (104).

154

Sørensen MV et al. Aldosterone increases KCa1.1 (BK) channel-mediated colonic K+ secretion.
J. Physiol. (Lond.), 2008 Sep 1 , 586 (4251-64).

155

Ohrtman J et al. Sequence differences in the IQ motifs of CaV1.1 and CaV1.2 strongly impact calmodulin binding and calcium-dependent inactivation.
J. Biol. Chem., 2008 Oct 24 , 283 (29301-11).

156

Struyk AF et al. Gating pore currents in DIIS4 mutations of NaV1.4 associated with periodic paralysis: saturation of ion flux and implications for disease pathogenesis.
J. Gen. Physiol., 2008 Oct , 132 (447-64).

157

Chabrier S et al. Early onset of hypokalaemic periodic paralysis caused by a novel mutation of the CACNA1S gene.
J. Med. Genet., 2008 Oct , 45 (686-8).

158

Ozaki H et al. Autonomously functioning thyroid nodule associated with thyrotoxic periodic paralysis.
Endocr. J., 2008 Mar , 55 (113-9).

159

Nakamoto T et al. Apical maxi-K (KCa1.1) channels mediate K+ secretion by the mouse submandibular exocrine gland.
Am. J. Physiol., Cell Physiol., 2008 Mar , 294 (C810-9).

160

Treves S et al. Congenital muscle disorders with cores: the ryanodine receptor calcium channel paradigm.
, 2008 Jun , 8 (319-26).

161

Meyer T et al. Progressive muscle atrophy with hypokalemic periodic paralysis and calcium channel mutation.
Muscle Nerve, 2008 Jan , 37 (120-4).

162

Tricarico D et al. Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats.
Neuromuscul. Disord., 2008 Jan , 18 (74-80).

163

Matza D et al. A scaffold protein, AHNAK1, is required for calcium signaling during T cell activation.
Immunity, 2008 Jan , 28 (64-74).

164

Stroffekova K Ca2+/CaM-dependent inactivation of the skeletal muscle L-type Ca2+ channel (Cav1.1).
Pflugers Arch., 2008 Feb , 455 (873-84).

165

Strube C Absence of regulation of the T-type calcium current by Cav1.1, beta1a and gamma1 dihydropyridine receptor subunits in skeletal muscle cells.
Pflugers Arch., 2008 Feb , 455 (921-7).

166

Fang X et al. Cloning, sequencing and identification of single nucleotide polymorphisms of partial sequence on the porcine CACNA1S gene.
Sci. China, C, Life Sci., 2008 Apr , 51 (317-25).

167

Bentzen BH et al. The small molecule NS11021 is a potent and specific activator of Ca2+-activated big-conductance K+ channels.
Mol. Pharmacol., 2007 Oct , 72 (1033-44).

168

Sandoval A et al. gamma1-dependent down-regulation of recombinant voltage-gated Ca2+ channels.
Cell. Mol. Neurobiol., 2007 Nov , 27 (901-8).

169

Houinato D et al. Hypokalaemic periodic paralysis due to the CACNA1S R1239H mutation in a large African family.
Neuromuscul. Disord., 2007 May , 17 (419-22).

170

Matos JE et al. Role of cholinergic-activated KCa1.1 (BK), KCa3.1 (SK4) and KV7.1 (KCNQ1) channels in mouse colonic Cl- secretion.
Acta Physiol (Oxf), 2007 Mar , 189 (251-8).

171

Kuzmenkin A et al. Gating of the HypoPP-1 mutations: I. Mutant-specific effects and cooperativity.
Pflugers Arch., 2007 Jun , 454 (495-505).

172

Kuzmenkin A et al. Gating of the HypoPP-1 mutations: II. Effects of a calcium-channel agonist BayK 8644.
Pflugers Arch., 2007 Jul , 454 (605-14).

173

Struyk AF et al. A Na+ channel mutation linked to hypokalemic periodic paralysis exposes a proton-selective gating pore.
J. Gen. Physiol., 2007 Jul , 130 (11-20).

174

Tang NL et al. The alpha(1S) subunit of the L-type calcium channel is not a predisposition gene for thyrotoxic periodic paralysis.
Clin. Endocrinol. (Oxf), 2007 Feb , 66 (229-34).

175

Kim JB et al. The genotype and clinical phenotype of Korean patients with familial hypokalemic periodic paralysis.
J. Korean Med. Sci., 2007 Dec , 22 (946-51).

176

Winczewska-Wiktor A et al. Myopathy as the first symptom of hypokalemic periodic paralysis--case report of a girl from a Polish family with CACNA1S (R1239G) mutation.
Adv Med Sci, 2007 , 52 Suppl 1 (155-7).

177

Carle T et al. Gating defects of a novel Na+ channel mutant causing hypokalemic periodic paralysis.
Biochem. Biophys. Res. Commun., 2006 Sep 22 , 348 (653-61).

178

Deng XL et al. Properties of ion channels in rabbit mesenchymal stem cells from bone marrow.
Biochem. Biophys. Res. Commun., 2006 Sep 15 , 348 (301-9).

179

Kageyama K et al. Gene analysis of the calcium channel 1 subunit and clinical studies for two patients with hypokalemic periodic paralysis.
J. Endocrinol. Invest., 2006 Nov , 29 (928-33).

180

Misonou H et al. Immunolocalization of the Ca2+-activated K+ channel Slo1 in axons and nerve terminals of mammalian brain and cultured neurons.
J. Comp. Neurol., 2006 May 20 , 496 (289-302).

181

Anderson AA et al. The junctional SR protein JP-45 affects the functional expression of the voltage-dependent Ca2+ channel Cav1.1.
J. Cell. Sci., 2006 May 15 , 119 (2145-55).

182

Ke Q et al. [The mutation R672H in SCN4A gene exists in Chinese patients with hypokalaemic periodic paralysis]
Zhonghua Yi Xue Za Zhi, 2006 Mar 21 , 86 (724-7).

183

Wu S et al. Central core disease is due to RYR1 mutations in more than 90% of patients.
Brain, 2006 Jun , 129 (1470-80).

184

Ke Q et al. [R1239H mutation of CACNA1S gene in a Chinese family with hypokalaemic periodic paralysis]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 2006 Jun , 23 (272-4).

185

Ivanov A et al. Adenylate cyclase 5 and KCa1.1 channel are required for EGFR up-regulation of PCNA in native contractile rat basilar artery smooth muscle.
J. Physiol. (Lond.), 2006 Jan 1 , 570 (73-84).

186

Venance SL et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment.
Brain, 2006 Jan , 129 (8-17).

187

Thompson J et al. Membrane-delimited inhibition of maxi-K channel activity by the intermediate conductance Ca2+-activated K channel.
J. Gen. Physiol., 2006 Feb , 127 (159-69).

188

Dranchak PK et al. Exclusion of linkage of the RYR1, CACNA1S, and ATP2A1 genes to recurrent exertional rhabdomyolysis in Thoroughbreds.
Am. J. Vet. Res., 2006 Aug , 67 (1395-400).

189

Fang XM et al. Mapping CACNA1S to chromosome 10 in swine using radiation hybrid mapping.
Anim. Genet., 2005 Oct , 36 (437).

190

Vicart S et al. Human skeletal muscle sodium channelopathies.
Neurol. Sci., 2005 Oct , 26 (194-202).

191

Monnier N et al. Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.
Hum. Mutat., 2005 Nov , 26 (413-25).

192

Wang Q et al. Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family.
J. Mol. Med., 2005 Mar , 83 (203-8).

193

Carbonneau L et al. Multiple loops of the dihydropyridine receptor pore subunit are required for full-scale excitation-contraction coupling in skeletal muscle.
Biophys. J., 2005 Jul , 89 (243-55).

194

Altafaj X et al. Maurocalcine and domain A of the II-III loop of the dihydropyridine receptor Cav 1.1 subunit share common binding sites on the skeletal ryanodine receptor.
J. Biol. Chem., 2005 Feb 11 , 280 (4013-6).

195

Wang Y et al. The solution structure of BmTx3B, a member of the scorpion toxin subfamily alpha-KTx 16.
Proteins, 2005 Feb 1 , 58 (489-97).

196

Lin SH et al. Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in chinese patients with hypokalemic periodic paralysis.
Am. J. Med. Sci., 2005 Feb , 329 (66-70).

197

Kim JB et al. A Korean family of hypokalemic periodic paralysis with mutation in a voltage-gated calcium channel (R1239G).
J. Korean Med. Sci., 2005 Feb , 20 (162-5).

198

Hulme JT et al. Sites of proteolytic processing and noncovalent association of the distal C-terminal domain of CaV1.1 channels in skeletal muscle.
Proc. Natl. Acad. Sci. U.S.A., 2005 Apr 5 , 102 (5274-9).

199

Schalin-Jantti C et al. Manifestation, management and molecular analysis of candidate genes in two rare cases of thyrotoxic hypokalemic periodic paralysis.
Horm. Res., 2005 , 63 (139-44).

200

Miller TM et al. Correlating phenotype and genotype in the periodic paralyses.
Neurology, 2004 Nov 9 , 63 (1647-55).

201

Dafi O et al. Negatively charged residues in the N-terminal of the AID helix confer slow voltage dependent inactivation gating to CaV1.2.
Biophys. J., 2004 Nov , 87 (3181-92).

202

Kim MK et al. Mutation screening in Korean hypokalemic periodic paralysis patients: a novel SCN4A Arg672Cys mutation.
Neuromuscul. Disord., 2004 Nov , 14 (727-31).

203

Links TP et al. [From gene to diseases; hypokalemic periodic paralysis]
, 2004 May 22 , 148 (1035-8).

204

Lunardi J et al. [Genetic of diseases by abnormal functioning of the skeletal muscle-calcium releasing complex]
Rev. Neurol. (Paris), 2004 May , 160 (S70-7).

205

Kawamura S et al. A family of hypokalemic periodic paralysis with CACNA1S gene mutation showing incomplete penetrance in women.
Intern. Med., 2004 Mar , 43 (218-22).

206

Carrillo E et al. Regulation of muscle Cav1.1 channels by long-term depolarization involves proteolysis of the alpha1s subunit.
J. Membr. Biol., 2004 Jun 1 , 199 (155-61).

207

Marchant CL et al. Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia.
Muscle Nerve, 2004 Jul , 30 (114-7).

208

Heimann P et al. Elimination by necrosis, not apoptosis, of embryonic extraocular muscles in the muscular dysgenesis mutant of the mouse.
Cell Tissue Res., 2004 Feb , 315 (243-7).

209

Vicart S et al. New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis.
Neurology, 2004 Dec 14 , 63 (2120-7).

210

Tricarico D et al. Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+-deficient rats.
FASEB J., 2004 Apr , 18 (760-1).

211

Carsana A et al. Identification of new polymorphisms in the CACNA1S gene.
Clin. Chem. Lab. Med., 2003 Jan , 41 (20-2).

212

Muniz VP et al. Screening for mutations in the RYR1 gene in families with malignant hyperthermia.
J. Mol. Neurosci., 2003 , 21 (35-42).

213

Monnier N et al. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility.
Anesthesiology, 2002 Nov , 97 (1067-74).

214

Dias Da Silva MR et al. Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis.
Clin. Endocrinol. (Oxf), 2002 Mar , 56 (367-75).

215

Lehmann-Horn F et al. Periodic paralysis: understanding channelopathies.
, 2002 Jan , 2 (61-9).

216

Lucet V et al. [Andersen syndrome, ventricular arrhythmias and channelopathy (a case report)]
, 2002 Dec , 9 (1256-9).

217

Kuzmenkin A et al. Enhanced inactivation and pH sensitivity of Na(+) channel mutations causing hypokalaemic periodic paralysis type II.
Brain, 2002 Apr , 125 (835-43).

218

Brooks C et al. No evidence of mutations in the CACNA1S gene in the UK malignant hyperthermia population.
, 2002 Apr , 88 (587-9).

219

Davies NP et al. Sodium channel gene mutations in hypokalemic periodic paralysis: an uncommon cause in the UK.
Neurology, 2001 Oct 9 , 57 (1323-5).

220

Ikeda Y et al. [Familial hypokalemic periodic paralysis]
, 2001 Nov , 11 (1464-7).

221

Kim SH et al. Identification of mutations including de novo mutations in Korean patients with hypokalaemic periodic paralysis.
Nephrol. Dial. Transplant., 2001 May , 16 (939-44).

222

Stewart SL et al. Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia.
Clin. Genet., 2001 Mar , 59 (178-84).

223

Sternberg D et al. Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A.
Brain, 2001 Jun , 124 (1091-9).

224

Katsuno M et al. [A case of familial hypokalemic periodic paralysis with hyperuricemia during paralytic attack and genetic analysis of the pedigree]
Rinsho Shinkeigaku, 2001 Jul , 41 (397-401).

225

Tricarico D et al. Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis.
Ann. Neurol., 2000 Sep , 48 (304-12).

226

Domínguez-Morán JA et al. Clinical-molecular study of a family with essential tremor, late onset seizures and periodic paralysis.
, 2000 Oct , 9 (493-7).

227

Wada T et al. Hypokalemic periodic paralysis and mutations in the CACNL1A3 gene: case study in a Japanese family.
Pediatr Int, 2000 Jun , 42 (325-7).

228

Struyk AF et al. The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation.
J. Neurosci., 2000 Dec 1 , 20 (8610-7).

229

Jurkat-Rott K et al. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current.
Proc. Natl. Acad. Sci. U.S.A., 2000 Aug 15 , 97 (9549-54).

230

Vainzof M et al. Does the A3333G mutation in the CACNL1A3 gene, detected in malignant hyperthermia, also occur in central core disease?
Genet. Test., 2000 , 4 (383-6).

231

Ruff RL Insulin acts in hypokalemic periodic paralysis by reducing inward rectifier K+ current.
Neurology, 1999 Oct 22 , 53 (1556-63).

232

Bulman DE et al. A novel sodium channel mutation in a family with hypokalemic periodic paralysis.
Neurology, 1999 Dec 10 , 53 (1932-6).

233

Morrill JA et al. Gating of the L-type Ca channel in human skeletal myotubes: an activation defect caused by the hypokalemic periodic paralysis mutation R528H.
J. Neurosci., 1998 Dec 15 , 18 (10320-34).

234

Lory P et al. [Physiopathology of calcium channels: identification of calcium channelopathies]
C. R. Seances Soc. Biol. Fil., 1998 , 192 (137-47).

235

Sillén A et al. Identification of mutations in the CACNL1A3 gene in 13 families of Scandinavian origin having hypokalemic periodic paralysis and evidence of a founder effect in Danish families.
Am. J. Med. Genet., 1997 Mar 3 , 69 (102-6).

236

Robinson RL et al. A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees.
Hum. Mol. Genet., 1997 Jun , 6 (953-61).

237

Lapie P et al. Hypokalemic periodic paralysis: an autosomal dominant muscle disorder caused by mutations in a voltage-gated calcium channel.
Neuromuscul. Disord., 1997 Jun , 7 (234-40).

238

Monnier N et al. Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle.
Am. J. Hum. Genet., 1997 Jun , 60 (1316-25).

239

Fouad G et al. Genotype-phenotype correlations of DHP receptor alpha 1-subunit gene mutations causing hypokalemic periodic paralysis.
Neuromuscul. Disord., 1997 Jan , 7 (33-8).

240

Ikeda Y et al. [Mutation analysis of the CACNL1A3 gene in Japanese hypokalemic periodic paralysis families]
Nippon Rinsho, 1997 Dec , 55 (3247-52).

241

Lapie P et al. Electrophysiological properties of the hypokalaemic periodic paralysis mutation (R528H) of the skeletal muscle alpha 1s subunit as expressed in mouse L cells.
FEBS Lett., 1996 Mar 18 , 382 (244-8).

242

Lerche H et al. Expression and functional characterization of the cardiac L-type calcium channel carrying a skeletal muscle DHP-receptor mutation causing hypokalaemic periodic paralysis.
Pflugers Arch., 1996 Jan , 431 (461-3).

243

Grosson CL et al. Hypokalemic periodic paralysis mutations: confirmation of mutation and analysis of founder effect.
Neuromuscul. Disord., 1996 Jan , 6 (27-31).

244

Hogan K et al. The structure of the gene encoding the human skeletal muscle alpha 1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3).
Genomics, 1996 Feb 1 , 31 (392-4).

245

Sipos I et al. Skeletal muscle DHP receptor mutations alter calcium currents in human hypokalaemic periodic paralysis myotubes.
J. Physiol. (Lond.), 1995 Mar 1 , 483 ( Pt 2) (299-306).

246

Iaizzo PA et al. Differential diagnosis of periodic paralysis aided by in vitro myography.
Neuromuscul. Disord., 1995 Mar , 5 (115-24).

247

Boerman RH et al. Mutation in DHP receptor alpha 1 subunit (CACLN1A3) gene in a Dutch family with hypokalaemic periodic paralysis.
J. Med. Genet., 1995 Jan , 32 (44-7).

248

Elbaz A et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families.
Am. J. Hum. Genet., 1995 Feb , 56 (374-80).

249

Lehmann-Horn F et al. Altered calcium currents in human hypokalemic periodic paralysis myotubes expressing mutant L-type calcium channels.
Soc. Gen. Physiol. Ser., 1995 , 50 (101-13).

250

Plassart E et al. Genetic heterogeneity in hypokalemic periodic paralysis (hypoPP).
Hum. Genet., 1994 Nov , 94 (551-6).

251

Fontaine B et al. Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families.
Nat. Genet., 1994 Mar , 6 (267-72).

252

Iles DE et al. Refined localization of the alpha 1-subunit of the skeletal muscle L-type voltage-dependent calcium channel (CACNL1A3) to human chromosome 1q32 by in situ hybridization.
Genomics, 1994 Feb , 19 (561-3).

253

Hogan K et al. Cloning of the human skeletal muscle alpha 1 subunit of the dihydropyridine-sensitive L-type calcium channel (CACNL1A3).
Genomics, 1994 Dec , 24 (608-9).

254

Sansone V et al. Mutation in the S4 segment of the adult skeletal sodium channel gene in an Italian paramyotonia congenita (PC) family.
, 1994 Dec , 15 (473-80).

255

Jurkat-Rott K et al. A calcium channel mutation causing hypokalemic periodic paralysis.
Hum. Mol. Genet., 1994 Aug , 3 (1415-9).

256

Drouet B et al. The gene coding for the alpha 1 subunit of the skeletal dihydropyridine receptor (Cchl1a3 = mdg) maps to mouse chromosome 1 and human 1q32.
Mamm. Genome, 1993 Sep , 4 (499-503).

257

Sudbrak R et al. Exclusion of malignant hyperthermia susceptibility (MHS) from a putative MHS2 locus on chromosome 17q and of the alpha 1, beta 1, and gamma subunits of the dihydropyridine receptor calcium channel as candidates for the molecular defect.
Hum. Mol. Genet., 1993 Jul , 2 (857-62).

258

Gregg RG et al. Assignment of the human gene for the alpha 1 subunit of the skeletal muscle DHP-sensitive Ca2+ channel (CACNL1A3) to chromosome 1q31-q32.
Genomics, 1993 Jan , 15 (107-12).

259

Casley WL et al. Exclusion of linkage between hypokalemic periodic paralysis (HOKPP) and three candidate loci.
Genomics, 1992 Oct , 14 (493-4).

260

Chin H et al. The gene for the alpha 1 subunit of the skeletal muscle dihydropyridine-sensitive calcium channel (Cchl1a3) maps to mouse chromosome 1.
Genomics, 1992 Dec , 14 (1089-91).